The conference provides an exclusive opportunity for over 350 experts working in different areas of the peptides industry to exchange their experiences, engage in scientific discussions and network with senior-level attendees about the most pressing challenges of the industry.
Peptides qualify to be used for various therapeutic solutions to address the growing horizons of medical challenges. It is estimated that the global peptide therapeutics market will reach $25 billion by 2018. Thanks to the opportunities novel technologies, applications and numerous studies focusing on peptides offer, the industry is flourishing more than ever.
The 2nd Annual Peptides Congress forms part of Oxford Global’s highly successful Biologics Series and is co-located with the 8th Annual Proteins & Antibodies Congress and the 3rd Annual Biosimilars & Biobetters Congress.
In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 20 speakers will present a full conference programme covering the topics outlined below. These topics have been compiled as a result of a comprehensive research process undertaken with our advisory board members including VPs, Directors, Senior Research Fellows and Professors from global pharmaceutical organisations and leading research institutions.
Day 1 – Enabling Technologies For Peptide Screening, Synthesis And Modification
Day one will explore enabling technologies for peptide screening, synthesis and modification. Internationally renowned leaders will address new approaches for high-throughput screening, novel peptide conjugation strategies to enhance potency and half-life and activating different synthesis technologies. Presentations will explore the future opportunities in peptide design and creating diversity within peptide libraries.
- Promising methods to extend half-life peptide capabilities
- Activating synthesis technologies: HLPC, mass spectrometry, microwave-assisted SPPS
- Enhancing peptide stability through PEGylation, cyclization and amino acid incorporation
- Updates in peptide self-assembly & macromolecular assembly
- Advances in research involving high affinity binding peptides
- Novel peptide applications for intracellular targets
- New approaches for high-throughput screening
Day 2 – Peptide Case Studies
Day two of the congress will focus on peptide case studies covering discovery, preclinical and clinical development, therapeutic applications, peptide formulation and delivery. Esteemed experts will deliver presentations on enhancing the oral bioavailability and drugability of peptides, updates in discovery and preclinical and clinical development. Delegates will also have the opportunity to learn about recent developments involving cell-penetrating peptides, macrocyclic, polypeptides and bioactive peptides.
- Updates in preclinical discovery and clinical development
- Innovative therapeutic applications for peptides
- Latest advances and future perspectives in peptide delivery
- Cell-penetrating peptides: opportunities, challenges and future directions
- New strategies utilizing routes of administration for peptide formulation
- Peptidomimetics: enhancing drugability and bioavailability
- Recent developments: macrocyclic, polypeptides and bioactive peptides
Confirmed speakers for 2015
Peptide Area Head Discovery Chemistry, pRED, Roche Innovation Centre Basel
Chief Scientific Officer, Bicycle Therapeutics Ltd
Principal Scientist, Pfizer
Principal Scientist, Novartis
Senior Vice President, EE DPU, RD Metabolic Pathways & Cardio Unit, GSK
Executive Vice President and Chief Scientific Officer, Zealand Pharma
Senior Director, R&D, MedImmune
Head of Rare Diseases Chemistry, Head of Chemical Biology, Pfizer
Professor, Division of Peptide Biochemistry, TU München
Principal Scientist, Early Discovery Biochemistry, Genentech
Director, Strategy and Innovation Sourcing Diabetes Research Unit, Novo Nordisk
Research Fellow & VP Structural Biology, UCB
Director, Clinical Development, Eisai Ltd
CSO, Lanthio Pharma
President & CEO, Protagonist Therapeutics
Joel Richard, Senior Vice President, Peptides – Head of CMCS Dreux Site, Ipsen
CPU Head, Peptides Chemistry, GlaxoSmithKline
Head of Peptides, Sanofi-Aventis
Principal Scientist, Parenteral Formulation Sciences, Merck
Submit a poster
For attendees interested in submitting a poster, there are opportunities now available. Your poster presentation will be located in the exhibition room for two days alongside other posters from senior scientists working in industry and academia.
How to submit your abstract
We will require:
- Poster title, Abstract (200 words or less)
- Principal author, Organisation, Mailing address
- Email, Telephone, Fax
- Additional authors
In order to secure your board space a fee of £250 plus VAT will be required. The poster should be presented as A0 (841mm x 1189mm) portrait size.
To take advantage of this opportunity you need to be registered as a paid delegate over the 2 days. We have limited spaces available so please register soon!
Who will attend
The 2nd Annual Peptides Congress is an exclusive event consisting of world-class keynote addresses and panel discussions designed specifically for senior level attendees from leading pharmaceutical and biopharmaceutical, biotechnology, diagnostics, academics, government, CRO and solution provider companies. Delegates typically include VPs, Directors, Managers and Heads of:
- Biologics Drug Discovery
- Biologics Research
- Biotherapeutics Research
- Discovery Chemistry
- Discovery Technologies
- Medicinal Chemistry
- Molecular Biology
- Peptide and Protein Chemistry
- Peptide Characterisation
- Peptide Delivery
- Peptide Development
- Peptide Discovery
- Peptide Engineering
- Peptide Formulation
- Peptide Optimisation
- Peptide Synthesis
- R&D Technologies
- Technology Innovation
- Therapeutic Peptides